Logo
Nazad
Z. Z. Weerts, L. Vork, Z. Mujagic, D. Keszthelyi, M. Hesselink, J. Kruimel, C. Leue, J. Muris, D. Jonkers, A. Masclee
34 22. 5. 2019.

Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndrome

Irritable bowel syndrome (IBS) is a brain‐gut disorder, of which the natural course varies between patients and is difficult to predict. This study aimed to evaluate symptom evolution over a 5‐year follow‐up period and to identify baseline predictors for symptom severity and quality of life (QoL) at follow‐up.


Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više